Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.
about
Proteus mirabilis and Urinary Tract Infections.Where does a Staphylococcus aureus vaccine stand?Escherichia coli in Europe: an overviewSslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsThe small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coliFrom in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challengesGenome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infectionBlocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.Virulence Genes and Antimicrobial Resistance Pattern in Uropathogenic Escherichia coli Isolated From Hospitalized Patients in Kashan, Iran.Public health evolutionary biology of antimicrobial resistance: priorities for interventionInhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli.Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical UropathogensMolecular and Structural Characterization of a Novel Escherichia coli Interleukin Receptor Mimic ProteinDevelopment of a Vaccine against Escherichia coli Urinary Tract Infections.Alternative approaches to conventional treatment of acute uncomplicated urinary tract infection in women.Pemphigus vulgaris and infections: a retrospective study on 155 patients.The nature of immune responses to urinary tract infectionsImmunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection.From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infectionsDraft genome sequences of five recent human uropathogenic Escherichia coli isolates.Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic Escherichia coli.Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infectionType 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli.Proteomic analysis of uropathogenic Escherichia coli.Obstetric and gynecological diseases and complications resulting from vaginal dysbacteriosis.Antiadhesion agents against Gram-positive pathogens.Effect of Aminophenyl and Aminothiahexyl α-D-Glycosides of the Manno-, Gluco-, and Galacto-Series on Type 1 Fimbriae-Mediated Adhesion of Escherichia coli.Multidrug-resistant Escherichia coli in Asia: epidemiology and management.The emerging threat of multidrug-resistant Gram-negative bacteria in urology.Therapies in early development for the treatment of urinary tract inflammation.E. coli Group 1 Capsular Polysaccharide Exportation Nanomachinary as a Plausible Antivirulence Target in the Perspective of Emerging Antimicrobial Resistance.What is the role of covert infection in detrusor overactivity, and other LUTD? ICI-RS 2013.Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.[Pathogenesis of urinary tract infections : An update].A high-throughput assay for the measurement of uropathogenic Escherichia coli attachment to urinary bladder cells.Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.Purification of intracellular bacterial communities during experimental urinary tract infection reveals an abundant and viable bacterial reservoir.Nanodiamonds facilitate killing of intracellular uropathogenic E. coli in an in vitro model of urinary tract infection pathogenesis.
P2860
Q26779002-0ACDF09D-BA98-49F2-9031-1B3149303565Q26828726-6A4929CA-257F-4B12-B84B-885376C182A4Q27015697-344D8D2B-540A-4CBC-B272-541BA62B358CQ27325713-E67BB444-3B5F-4815-A887-C4D83AE0CED9Q28248484-A087C7D4-C750-4286-9905-C569CE992B40Q30424697-C908716B-42A0-4E73-A86A-DD090E360167Q34297628-033A7CCF-294C-4DF1-9F27-3CB177657E03Q35067216-8158E642-A652-42D4-8C48-1B5146C81F48Q35187514-EA0396A7-6D0E-4B18-9E4C-EFB0E7F70D1FQ35225481-1020F585-90FD-4EAE-868E-7C2AB359BE8AQ35236703-848D580C-94AF-4107-9DCD-38446D44D4A4Q35687994-FD5C097F-22D1-40A4-AF1A-0A9876C32A9CQ36124083-AA82864B-C6F0-494A-A493-6BF071E37AA3Q36677371-6FA10D3E-3FA8-4D91-8F8B-DC5D3DC9BE6CQ36727670-E741C94A-8965-43B5-8469-BA8E686510E6Q36735378-5CDF6BA0-8A53-44AF-9AEE-ED515B318FC4Q36754301-0D9465BD-C5FA-4E30-81FF-6F2BF60E37E2Q36969571-32AC121B-DE9A-4266-AAF4-780D424BC363Q37050386-CF3C43EA-BDC3-498A-83D9-20CCBACD4230Q37123720-2F38D362-B1DD-44F1-ADA9-0F3999EDC98EQ37230837-3E110993-675D-4FF5-AED5-C2C20C5A73DCQ37350912-FF8EEDB1-691A-446B-BC6F-1C3BF7CF97A9Q37379982-86C672C7-9E47-4363-9033-30267D363101Q37451220-26E2C1CF-1B0E-442A-9D4A-52F116926D57Q37643400-A2A4B9DF-3E6C-44DC-8E8F-819B28AC07F2Q38176076-96354D49-9F59-424B-A3AC-B650CC5523F8Q38202912-23761DFC-C21B-4AD9-874C-A711C991E1A6Q38269150-A4B08E74-BC8A-4440-B8A6-03171766053EQ38369339-5924C961-9AE9-455C-ABE1-22314BECECFDQ38389612-52CDEA22-2A42-4B01-A31C-BD4579A837DBQ38579512-91A1590A-D81B-498B-B278-91C7696A6714Q38757968-4CC8214B-5A00-41DF-A07C-4BEA61C684E8Q39143538-5C2CF969-41BE-48CE-B20C-791BC35B0CEBQ39189283-B4F446F9-8CF9-4CF8-B04F-8ED0D74C261CQ40199741-4BDBD56D-3B84-4DE9-94AB-A7F4B248A501Q40233051-5DC005B9-D11E-47EC-945F-F2F37BF0A41CQ40641500-DA288D03-352C-471E-A640-4EA96079C817Q40757720-91F55E89-708D-4F7D-89D3-53D86AD1E26AQ47706415-7A4E1EEA-CDE1-4C41-A46E-F9B55D704EE4Q48259672-508AFCBD-644D-4727-BDCA-139BDE75D1B3
P2860
Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@ast
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@en
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@nl
type
label
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@ast
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@en
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@nl
prefLabel
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@ast
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@en
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@nl
P2860
P356
P1476
Preventing urinary tract infec ...... tive Escherichia coli vaccine.
@en
P2093
Ariel R Brumbaugh
P2860
P304
P356
10.1586/ERV.12.36
P577
2012-06-01T00:00:00Z